paclitaxel has been researched along with Hypothyroidism in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, W; Fang, B; Hao, W; Jin, S; Wang, Y; Yuan, J; Zhang, J | 1 |
| Ni, J; Zhang, L; Zhang, X | 1 |
| Fong, KW; Hussain, A; Ong, WS; Sommat, K; Soong, YL; Tan, T; Wee, J | 1 |
| Blohmer, JU; Burchardi, N; Denkert, C; Engels, K; Fasching, PA; Furlanetto, J; Grischke, EM; Hanusch, C; Huober, J; Jackisch, C; Kümmel, S; Loibl, S; Rautenberg, B; Rezai, M; Rhiem, K; Schmitt, WD; Schneeweiss, A; Sinn, BV; Tesch, H; Thomalla, J; Untch, M; von Minckwitz, G; Weber, K | 1 |
| Bair, SM; Cherpelis, BS; Fenske, NA; Glass, LF; Marquez, CB; Smithberger, EE; Wenham, RM | 1 |
| Chung, CH; Cmelak, AJ; Diaz, R; Gilbert, J; Jaboin, JJ; Koehler, E; Morales-Paliza, M; Murphy, BA; Murphy, PB; Phillips, JG; Shyr, Y; Stinson, S; Yarbrough, WG | 1 |
| Díaz-Rubio, E; López-Tarruella, S; Manzano, A; Martin, M; Puente, J | 1 |
| Kalofonos, HP; Kosmas, C; Kourelis, T; Koutras, A; Makatsoris, T; Onienadoum, A; Sofroniadou, S | 1 |
1 review(s) available for paclitaxel and Hypothyroidism
| Article | Year |
|---|---|
Immune-related adverse events associated with nab-paclitaxel/paclitaxel combined with immune checkpoint inhibitors: a systematic review and network meta-analysis.
Topics: Antineoplastic Agents, Immunological; B7-H1 Antigen; Humans; Hypothyroidism; Immune Checkpoint Inhibitors; Neoplasms; Network Meta-Analysis; Paclitaxel; Pneumonia; Programmed Cell Death 1 Receptor | 2023 |
2 trial(s) available for paclitaxel and Hypothyroidism
| Article | Year |
|---|---|
Thyroid V40 Predicts Primary Hypothyroidism After Intensity Modulated Radiation Therapy for Nasopharyngeal Carcinoma.
Topics: Adult; Age Factors; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Chemoradiotherapy; Cisplatin; Deoxycytidine; Female; Follow-Up Studies; Gemcitabine; Humans; Hypothyroidism; Incidence; Induction Chemotherapy; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Paclitaxel; Pituitary Gland; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Regression Analysis; Thyroid Gland; Time Factors | 2017 |
A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study.
Topics: Adult; Aged; Albumins; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Biomarkers, Tumor; Breast; Cyclophosphamide; Double-Blind Method; Epirubicin; Female; Humans; Hyperthyroidism; Hypothyroidism; Lymphocytes, Tumor-Infiltrating; Mastectomy; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Placebos; Prospective Studies; Receptor, ErbB-2; Thyroid Gland; Treatment Outcome; Triple Negative Breast Neoplasms; Young Adult | 2019 |
5 other study(ies) available for paclitaxel and Hypothyroidism
| Article | Year |
|---|---|
Marked elevation of creatine phosphokinase alone caused by sintilimab - beware of hypothyroid myopathy.
Topics: Adenocarcinoma of Lung; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Asymptomatic Diseases; Creatine Kinase; Humans; Hypothyroidism; Lung Neoplasms; Male; Middle Aged; Muscular Diseases; Paclitaxel; Thyroxine | 2020 |
Multiple keratoacanthomas arising in the setting of sorafenib therapy: novel chemoprophylaxis with bexarotene.
Topics: Adenocarcinoma, Papillary; Anticarcinogenic Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Bexarotene; Carboplatin; Clinical Trials as Topic; Cystadenocarcinoma, Serous; Dose-Response Relationship, Drug; Female; Humans; Hypertriglyceridemia; Hypothyroidism; Keratoacanthoma; Middle Aged; Neoplasm Recurrence, Local; Niacinamide; Ovarian Neoplasms; Paclitaxel; Phenylurea Compounds; Pyridines; Skin Diseases; Sorafenib; Tetrahydronaphthalenes | 2009 |
Hypothyroidism as a consequence of intensity-modulated radiotherapy with concurrent taxane-based chemotherapy for locally advanced head-and-neck cancer.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carboplatin; Combined Modality Therapy; Dose Fractionation, Radiation; Female; Head and Neck Neoplasms; Humans; Hypothyroidism; Male; Middle Aged; Paclitaxel; Radiation Injuries; Radiography; Radiotherapy, Intensity-Modulated; Retrospective Studies; Risk Factors; Taxoids; Thyroid Gland | 2010 |
Breast cancer: complete response with the combination of sunitinib and trastuzumab in a patient with grade III ductal carcinoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Diarrhea; Female; Heart Function Tests; Humans; Hypothyroidism; Indoles; Lymphatic Metastasis; Middle Aged; Paclitaxel; Pyrroles; Remission Induction; Sunitinib; Trastuzumab | 2010 |
Absence of chemotherapy-induced alopecia with paclitaxel in a case of hypothyroidism: case report.
Topics: Aged; Alopecia; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cystadenocarcinoma, Serous; Female; Hair; Humans; Hypothyroidism; Ovarian Neoplasms; Paclitaxel | 2003 |